>
pdufa.bio

UCART22

Updated ยทnext FDA decision on the calendar

UCART22 is a Cellectis S.A. program. Every date links its source.

CLLS catalyst hub

All upcoming FDA decision dates on the 2026 PDUFA calendar

About this program

Sponsor: Cellectis S.A. (CLLS). We track 1 catalyst event for this program: 0 upcoming and 1 in the record. A PDUFA date is the FDA's target date to complete review of a marketing application; a readout is the sponsor's expected date for clinical trial results. What a PDUFA date is · why we do not compare trial results across drugs.

Catalyst history

Readout · Jun 2026CLLS

Questions

When is UCART22's next FDA decision or readout?

No upcoming catalyst is on our calendar for UCART22; no FDA decisions are on record below.

What happened at UCART22's most recent FDA decision?

No FDA decision for UCART22 is in our archive yet.

Who makes UCART22?

Cellectis S.A. (CLLS).

Where does this data come from?

FDA announcements, sponsor press releases and SEC filings; every date on this page links its source.